Trejo Bittar Humberto E, Radder Josiah E, Ranganathan Sarangarajan, Srinivasan Abhay, Madan-Khetarpal Suneeta, Reyes-Múgica Miguel
1 Division of Pediatric Pathology, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Pediatr Dev Pathol. 2014 Jul-Aug;17(4):297-301. doi: 10.2350/14-03-1450-CR.1. Epub 2014 Apr 15.
Patients with Fanconi anemia subgroup D1, attributable to biallelic mutations in BRCA2, have an increased risk of solid tumors. Tumors in the kidneys of these patients are almost exclusively Wilms tumor. We report the first recorded case, to our knowledge, of a Clear Cell Sarcoma of the Kidney in a patient with this cancer predisposition syndrome. We review different aspects of the need for careful clinical observation in patients of this complementation group, given their risk for malignancy.
由于BRCA2双等位基因突变导致的范可尼贫血D1亚组患者,患实体瘤的风险增加。这些患者肾脏中的肿瘤几乎都是威尔姆斯瘤。据我们所知,我们报告了首例患有这种癌症易感性综合征的患者发生肾透明细胞肉瘤的病例。鉴于该互补组患者有患恶性肿瘤的风险,我们回顾了对此类患者进行仔细临床观察的不同方面。